RISK

Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning

HEAD-TO-HEAD COMPARISON · 2026

Seven Points Capital vs LiquidityX

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

S7PC

Seven Points Capital

EST. 2007

LQDX

LiquidityX

EST. 2026

SEVEN POINTS CAPITAL

METRIC

LIQUIDITYX

0/100TIE

TRUST SCORE

TIE0/100

0/5TIE

RATING

TIE0/5

—

PROFIT SPLIT

—

MAX FUNDING

—

MIN COST

—

PAYOUT DAYS

—

PASS RATE

—

0TIE

REVIEW COUNT

TIE0

SEVEN POINTS CAPITAL DETAILS

STEPS: -phase

LIQUIDITYX DETAILS

STEPS: -phase

Seven Points Capital PROS

+Founded in 2007, indicating over 15 years of operational longevity in the industry
+No data is available on profit split to compare against the 84.7% industry average
+No data is available on max funding to compare against the $839,272.7 industry average
+No data is available on challenge cost to compare against the $186.7 industry average

Seven Points Capital CONS

−Virtually no financial or trading metrics are provided beyond founding date and country
−Traders cannot assess payout speed relative to the industry average of 6.5 days
−Absence of drawdown, profit target, and steps data prevents any meaningful comparison

LiquidityX PROS

+Placeholder pro — no data provided beyond founding year; no metrics to evaluate
+Placeholder pro — no data provided beyond founding year; no metrics to evaluate
+Placeholder pro — no data provided beyond founding year; no metrics to evaluate
+Placeholder pro — no data provided beyond founding year; no metrics to evaluate

LiquidityX CONS

−Founded in 2026, meaning this firm does not yet exist at time of writing
−A future founding date raises serious concerns about legitimacy and operational status
−No trading metrics are available to compare against any industry averages

PROPDNA VERDICT